BCX9930

Factor D inhibitor · BioCryst Pharmaceuticals

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for BCX9930, covering 2022-02-17 to 2025-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Safety of BCX9930 in Participants With Paroxysmal Nocturnal Hemoglobinuria [Phase 2]